Incidence of congenital toxoplasmosis estimated by neonatal screening: Relevance of diagnostic confirmation in asymptomatic newborn infants

Epidemiology and Infection

Volumn 133, Issue 3, 2005, Pages 485-491

  Carvalheiro, C G ^a   Mussi Pinhata, M M ^a,b   Yamamoto, A Y ^a   De Souza, C B S ^a   Maciel, L M Z ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b NONE   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; PROTOZOON ANTIBODY; IMMUNOGLOBULIN M;

ANTIBODY DETECTION; ARTICLE; BLOOD SAMPLING; BRAZIL; CONGENITAL TOXOPLASMOSIS; HUMAN; INCIDENCE; NEWBORN; NEWBORN SCREENING; NORMAL HUMAN; SCREENING TEST; TOXOPLASMA; ANIMAL; BLOOD; EVALUATION; FEMALE; IMMUNOLOGY; ISOLATION AND PURIFICATION; MALE; METHODOLOGY; PREDICTION AND FORECASTING;

ANIMALS; ANTIBODIES, PROTOZOAN; BRAZIL; FEMALE; HUMANS; IMMUNOGLOBULIN M; INCIDENCE; INFANT, NEWBORN; MALE; NEONATAL SCREENING; PREDICTIVE VALUE OF TESTS; TOXOPLASMA; TOXOPLASMOSIS, CONGENITAL;

EID: 20844457427     PISSN: 09502688     EISSN: None     Source Type: Journal    
DOI: 10.1017/S095026880400353X     Document Type: Article

References (33)

1. Remington JS, McLeod R, Desmonts G, Thulliez P. Toxoplasmosis. In: Remington JS, Klein JO, eds. Infectious diseases of the fetus and newborn infant, 5th edn. Philadelphia: Saunders, 2001: 205-346.
2. Guerina NG, Hsu HW, Meissner C, et al. Neonatal serologic screening and early treatment for congenital Toxoplasma gondii infection. N Engl J Med 1994; 330: 1858-1863.
3. Wilson CB, Remington JS, Stagno S, Reynolds DW. Development of adverse sequelae in children born with subclinical congenital Toxoplasma infection. Pediatrics 1980; 66: 767-774.
4. Koppe J, Loewer-Sieger DH, DeRoever-Bonnet H. Results of 20-year follow-up of congenital toxoplasmosis. Lancet 1986; 1: 254-256.
5. McAuley J, Boyer KM, Patel D, et al. Early and longitudinal evaluations of treated infants and children and untreated historical patients with congenital toxoplasmosis: the Chicago Collaborative Treatment Trial. Clin Infect Dis 1994; 18: 38-72.
6. Szénási Z, Ozsvár Z, Nagy E, et al. Prevention of congenital toxoplasmosis in Szeged, Hungary. Int J Epidemiol 1997; 26: 428-435.
7. Jenum PA, Stray-Pedersen B, Melby KK, et al. Incidence of Toxoplasma gondii infection in 35,940 pregnant women in Norway and pregnancy outcome for infected women. J Clin Microbiol 1998; 36: 2900-2906.
8. Ambroise-Thomas P, Schweitzer M, Pinon JM, Thiebaugeorges O. Prevention of congenital toxoplasmosis in France. Risk assessment. Results and perspectives of prenatal screening and newborn follow up [in French]. Bull Acad Natl Méd 2001; 183: 665-683.
9. Lebech M, Andersen O, Christensen NC, et al. Feasibility of neonatal screening for toxoplasma infection in the absence of prenatal treatment. Lancet 1999; 353: 1834-1837.
10. Evengård B, Petersson K, Engman ML, et al. Low incidence of toxoplasma infection during pregnancy and in newborns in Sweden. Epidemiol Infect 2001; 127: 121-127.
11. Logar J, Petrovec M, Novak-Antolič Ž, et al. Prevention of congenital toxoplasmosis in Slovenia by serological screening of pregnant women. Scand J Infect Dis 2002; 34: 201-204.
12. Duarte G, Paschoini MC, Martinez R, Ramos DM, Turco F. Seroepidemiological evaluation of toxoplasmosis in puerperae [in Portuguese]. Rev Bras Ginec Obstet 1999; 21: 175.
13. Rey LC, Ramalho ILC. Seroprevalence of toxoplasmosis in Fortaleza, Cearà, Brazil [in Portuguese]. Rev Inst Med Trop S Paulo 1999; 41: 171-174.
14. Reiche EMV, Morimoto HK, Farias GN, et al. Prevalence of American trypanosomiasis, syphilis, toxoplasmosis, rubella, hepatitis B, hepatitis C, human immunodeficiency virus infection, assayed through serological tests among pregnant patients, from 1996 to 1998, at the Regional University Hospital Norte do Paraná [in Portuguese]. Rev Soc Bras Med Trop 2000; 33: 519-527.
15. Spalding SM, Amendoeira MRR, Ribeiro LC, Silveira C, Garcia AP, Camillo-Coura L. Prospective study of pregnants and babies with risk of congenital toxoplasmosis in municipal district of Rio Grande do Sul [in Portuguese]. Rev Soc Bras Med Trop 2003; 36: 483-491.
16. Varella IS, Wagner MB, Darela AC, Nunes LM, Muller RW. Seroprevalence of toxoplasmosis in pregnant women [in Portuguese]. J Pediatr (Rio J) 2003; 79: 69-74.
17. Camargo Neto E, Anele E, Rubim R, et al. High prevalence of congenital toxoplasmosis in Brazil estimated in a 3-year prospective neonatal screening study. Int J Epidemiol 2000; 29: 941-947.
18. Petersen E, Pollak A, Reiter-Owona I. Recent trends in research on congenital toxoplasmosis. Int J Parasitol 2001; 31: 115-144.
19. Mozzatto L, Procianoy RS. Incidence of congenital toxoplasmosis in southern Brazil: a prospective study. Rev Inst Med Trop S Paulo 2003; 45: 147-151.
20. Lebech M, Johnson DHM, Seitz HM, et al. Classification system and case definitions of Toxoplasma gondii infection in immunocompetent pregnant women and their congenitally infected offspring. Eur J Clin Microbiol Infect Dis 1996; 15: 799-805.
21. Frenkel JK. Breaking the transmission chain of Toxoplasma: a program for the prevention of human toxoplasmosis. Bull NY Acad Sci 1974; 50: 228-234.
22. Eaton RB, Petersen E, Seppänen H, Tuuminen T. Multicenter evaluation of a fluorometric enzyme immunocapture assay to detect Toxoplasma-specific immunoglobulin M in dried blood filter paper specimens from newborns. J Clin Microbiol 1996; 34: 3147-3150.
23. Yamamoto AY, Mussi-Pinhata MM, Pinto PC, Figueiredo LT, Jorge SM. Usefulness of blood and urine samples collected on filter paper in detecting cytomegalovirus by the polymerase chain reaction technique. J Virol Methods 2001; 97: 159-164.
24. Paul M, Petersen E, Pawlowski ZS, Szczapa J. Neonatal screening for congenital toxoplasmosis in the Poznań region of Poland by analysis of Toxoplasma gondii-specific IgM antibodies eluted from filter paper blood spots. Pediatr Infect Dis J 2000; 19: 30-36.
25. Berger R, Stürchler D, Rudin C. Cord blood screening for congenital toxoplasmosis: detection and treatment of asymptomatic newborns in Basel, Switzerland. Scand J Infect Dis (Suppl) 1992; 84: 46-50.
26. Thoumsin H, Senterre J, Lambotte R. Twenty-two years screening for toxoplasmosis in pregnancy: Liége - Belgium. Scand J Infect Dis (Suppl) 1992; 84: 84-85.
27. Pinon JM, Dumon H, Chemla C, et al. Strategy for diagnosis of congenital toxoplasmosis: evaluation of methods for postnatal detection of immunoglobulin G, M and A antibodies. J Clin Microbiol 2001; 39: 2267-2271.
28. Wallon M, Dunn D, Slimani D, Girault V, Gay-Andrieu F, Peyron F. Diagnosis of congenital toxoplasmosis at birth: what is the value of testing for IgM and IgA? Eur J Pediatr 1999; 158: 645-649.
29. Naessens A, Jenum PA, Pollak A, et al. Diagnosis of congenital toxoplasmosis in the neonatal period: a multicenter evaluation. J Pediatr 1999; 135: 714-719.
30. Fletcher RH, Fletcher SW, Wagner EH. Clinical epidemiology: the essentials [in Portuguese], 3rd edn. Porto Alegre: Artes Médicas, 1996.
31. Mets MB, Holfels E, Boyer KM, et al. Eye manifestations of congenital toxoplasmosis. Am J Ophthalmol 1996; 122: 309-324.
32. Gilbert RE, Stanford MR. Is ocular toxoplasmosis caused by prenatal or postnatal infection? Br J Ophthalmol 2000; 84: 224-226.
33. Ajzenberg D, Cogné N, Paris L, et al. Genotype of 86 Toxoplasma gondii isolates associated with human congenital toxoplasmosis, and correlation with clinical findings. J Infect Dis 2002; 186: 684-689.